Compare $BBNX vs $IART | Chartloom

Compare

$BBNX vs $IART

Beta Bionics Inc · Integra Lifesciences Holdings Corp

BBNX

Beta Bionics Inc

IART

Integra Lifesciences Holdings Corp

Compare $BBNX vs $IART

Comparing Beta Bionics Inc and Integra Lifesciences Holdings Corp

BBNXBeta Bionics Inc

IARTIntegra Lifesciences Holdings Corp

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

IARTIntegra Lifesciences Holdings Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

4.99x

Forward P/S (NTM)

0.60x

Rev growth (TTM)

0.8%

YTD performance

11.9%

52W performance

-9.3%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBNX

IART

Detailed metrics comparison

BBNX

Beta Bionics Inc

IART

Integra Lifesciences Holdings Corp

Market Cap

BBNX$793M

IART$1.05B

Enterprise Value

BBNX$749M

IART$1.05B

Price

BBNX$17.63

IART$13.44

P/E Ratio

BBNXN/A

IARTN/A

P/S Ratio

BBNX6.66x

IART0.63x

EV/Sales

BBNX6.29x

IART0.63x

EV/EBITDA

BBNX0.00x

IART3.92x

P/B Ratio

BBNX3.99x

IART0.95x

P/FCF Ratio

BBNXN/A

IARTN/A

EV/FCF

BBNX-12.19x

IART-73.87x

PEG Ratio

BBNXN/A

IARTN/A

Forward P/E (NTM)

BBNXN/A

IART4.99x

Forward P/S (NTM)

BBNX5.37x

IART0.60x

Revenue (TTM)

BBNX$119M

IART$1.66B

Revenue Growth (YoY)

BBNX94.1%

IART0.8%

Forward Rev Growth

BBNX34.2%

IART3.2%

Gross Margin (TTM)

BBNX58.3%

IART43.1%

Operating Margin (TTM)

BBNX0.0%

IART4.0%

EBITDA Margin (TTM)

BBNX-67.9%

IART16.1%

Net Margin (TTM)

BBNX-61.3%

IART-0.1%

FCF Margin (TTM)

BBNX-51.6%

IART-0.9%

Net Income (TTM)

BBNX$-73M

IART$-2M

FCF (TTM)

BBNX$-61M

IART$-14M

EPS (TTM)

BBNX-$1.64

IART$0.00

ROE (TTM)

BBNX-2630.0%

IART-70.0%

ROA (TTM)

BBNX-2325.0%

IART-20.0%

ROIC (TTM)

BBNX-2630.0%

IART-25.0%

Cash

BBNX$44M

IART$0

Debt

BBNX$0

IART$0

Net Cash/Debt

BBNX$44M

IART$0

Current Ratio (TTM)

BBNX8.88x

IART3.60x

Quick Ratio (TTM)

BBNX7.72x

IART1.80x

Debt/Equity (TTM)

BBNX0.00x

IART1.79x

Debt/Assets (TTM)

BBNX0.0%

IART0.0%

Interest Coverage (TTM)

BBNXN/A

IARTN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

IART0.00x

Beta

BBNX0.92

IART1.27

52W Performance

BBNX-20.3%

IART-9.3%

YTD Performance

BBNX-39.7%

IART11.9%

% from 52W High

BBNX-46.1%

IART-34.4%

% from 52W Low

BBNX100.3%

IART54.5%

Asset Turnover (TTM)

BBNX0.38x

IART0.46x

FCF Yield (TTM)

BBNX-7.7%

IART-1.4%

Earnings Yield (TTM)

BBNX-9.2%

IART-0.2%

Dividend Yield (TTM)

BBNXN/A

IARTN/A

Rule of 40

BBNX42.5

IART-0.0

EV/GP/RG

BBNX0.34

IART0.26

Ticker research

View BBNX research View IART research

Metric	BBNX Beta Bionics Inc	IART Integra Lifesciences Holdings Corp
Market & Valuation
Market Cap	$793M	$1.05B
Enterprise Value	$749M	$1.05B
Price	$17.63	$13.44
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	0.63x
EV/Sales	6.29x	0.63x
EV/EBITDA	0.00x	3.92x
P/B Ratio	3.99x	0.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-73.87x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	4.99x
Forward P/S (NTM)	5.37x	0.60x
Revenue & Growth
Revenue (TTM)	$119M	$1.66B
Revenue Growth (YoY)	94.1%	0.8%
Forward Rev Growth	34.2%	3.2%
Profitability
Gross Margin (TTM)	58.3%	43.1%
Operating Margin (TTM)	0.0%	4.0%
EBITDA Margin (TTM)	-67.9%	16.1%
Net Margin (TTM)	-61.3%	-0.1%
FCF Margin (TTM)	-51.6%	-0.9%
Net Income (TTM)	$-73M	$-2M
FCF (TTM)	$-61M	$-14M
EPS (TTM)	-$1.64	$0.00
ROE (TTM)	-2630.0%	-70.0%
ROA (TTM)	-2325.0%	-20.0%
ROIC (TTM)	-2630.0%	-25.0%
Financial Health
Cash	$44M	$0
Debt	$0	$0
Net Cash/Debt	$44M	$0
Current Ratio (TTM)	8.88x	3.60x
Quick Ratio (TTM)	7.72x	1.80x
Debt/Equity (TTM)	0.00x	1.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.27
52W Performance	-20.3%	-9.3%
YTD Performance	-39.7%	11.9%
% from 52W High	-46.1%	-34.4%
% from 52W Low	100.3%	54.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.46x
FCF Yield (TTM)	-7.7%	-1.4%
Earnings Yield (TTM)	-9.2%	-0.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-0.0
EV/GP/RG	0.34	0.26
Ticker research	View BBNX research	View IART research

Valuation

P/S Ratio

IART

0.63x

BBNX

6.66x

EV/FCF

IART

-73.87x

BBNX

-12.19x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

IART

0.8%

Forward Revenue Growth

BBNX

34.2%

IART

3.2%

Profitability & performance

Gross Margin

BBNX

58.3%

IART

43.1%

ROE

IART

-70.0%

BBNX

-2630.0%

FCF Yield %

IART

-1.4%

BBNX

-7.7%

52-Week Performance

IART

-9.3%

BBNX

-20.3%

Detailed metrics comparison

BBNX

Beta Bionics Inc

IART

Integra Lifesciences Holdings Corp

Market Cap

BBNX$793M

IART$1.05B

Enterprise Value

BBNX$749M

IART$1.05B

Price

BBNX$17.63

IART$13.44

P/E Ratio

BBNXN/A

IARTN/A

P/S Ratio

BBNX6.66x

IART0.63x

EV/Sales

BBNX6.29x

IART0.63x

EV/EBITDA

BBNX0.00x

IART3.92x

P/B Ratio

BBNX3.99x

IART0.95x

P/FCF Ratio

BBNXN/A

IARTN/A

EV/FCF

BBNX-12.19x

IART-73.87x

PEG Ratio

BBNXN/A

IARTN/A

Forward P/E (NTM)

BBNXN/A

IART4.99x

Forward P/S (NTM)

BBNX5.37x

IART0.60x

Revenue (TTM)

BBNX$119M

IART$1.66B

Revenue Growth (YoY)

BBNX94.1%

IART0.8%

Forward Rev Growth

BBNX34.2%

IART3.2%

Gross Margin (TTM)

BBNX58.3%

IART43.1%

Operating Margin (TTM)

BBNX0.0%

IART4.0%

EBITDA Margin (TTM)

BBNX-67.9%

IART16.1%

Net Margin (TTM)

BBNX-61.3%

IART-0.1%

FCF Margin (TTM)

BBNX-51.6%

IART-0.9%

Net Income (TTM)

BBNX$-73M

IART$-2M

FCF (TTM)

BBNX$-61M

IART$-14M

EPS (TTM)

BBNX-$1.64

IART$0.00

ROE (TTM)

BBNX-2630.0%

IART-70.0%

ROA (TTM)

BBNX-2325.0%

IART-20.0%

ROIC (TTM)

BBNX-2630.0%

IART-25.0%

Cash

BBNX$44M

IART$0

Debt

BBNX$0

IART$0

Net Cash/Debt

BBNX$44M

IART$0

Current Ratio (TTM)

BBNX8.88x

IART3.60x

Quick Ratio (TTM)

BBNX7.72x

IART1.80x

Debt/Equity (TTM)

BBNX0.00x

IART1.79x

Debt/Assets (TTM)

BBNX0.0%

IART0.0%

Interest Coverage (TTM)

BBNXN/A

IARTN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

IART0.00x

Beta

BBNX0.92

IART1.27

52W Performance

BBNX-20.3%

IART-9.3%

YTD Performance

BBNX-39.7%

IART11.9%

% from 52W High

BBNX-46.1%

IART-34.4%

% from 52W Low

BBNX100.3%

IART54.5%

Asset Turnover (TTM)

BBNX0.38x

IART0.46x

FCF Yield (TTM)

BBNX-7.7%

IART-1.4%

Earnings Yield (TTM)

BBNX-9.2%

IART-0.2%

Dividend Yield (TTM)

BBNXN/A

IARTN/A

Rule of 40

BBNX42.5

IART-0.0

EV/GP/RG

BBNX0.34

IART0.26

Ticker research

View BBNX research View IART research

Metric	BBNX Beta Bionics Inc	IART Integra Lifesciences Holdings Corp
Market & Valuation
Market Cap	$793M	$1.05B
Enterprise Value	$749M	$1.05B
Price	$17.63	$13.44
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	0.63x
EV/Sales	6.29x	0.63x
EV/EBITDA	0.00x	3.92x
P/B Ratio	3.99x	0.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-73.87x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	4.99x
Forward P/S (NTM)	5.37x	0.60x
Revenue & Growth
Revenue (TTM)	$119M	$1.66B
Revenue Growth (YoY)	94.1%	0.8%
Forward Rev Growth	34.2%	3.2%
Profitability
Gross Margin (TTM)	58.3%	43.1%
Operating Margin (TTM)	0.0%	4.0%
EBITDA Margin (TTM)	-67.9%	16.1%
Net Margin (TTM)	-61.3%	-0.1%
FCF Margin (TTM)	-51.6%	-0.9%
Net Income (TTM)	$-73M	$-2M
FCF (TTM)	$-61M	$-14M
EPS (TTM)	-$1.64	$0.00
ROE (TTM)	-2630.0%	-70.0%
ROA (TTM)	-2325.0%	-20.0%
ROIC (TTM)	-2630.0%	-25.0%
Financial Health
Cash	$44M	$0
Debt	$0	$0
Net Cash/Debt	$44M	$0
Current Ratio (TTM)	8.88x	3.60x
Quick Ratio (TTM)	7.72x	1.80x
Debt/Equity (TTM)	0.00x	1.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.27
52W Performance	-20.3%	-9.3%
YTD Performance	-39.7%	11.9%
% from 52W High	-46.1%	-34.4%
% from 52W Low	100.3%	54.5%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.46x
FCF Yield (TTM)	-7.7%	-1.4%
Earnings Yield (TTM)	-9.2%	-0.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-0.0
EV/GP/RG	0.34	0.26
Ticker research	View BBNX research	View IART research